Biologic Therapies Targeting Eosinophils: Current Status and Future Prospects Fanny Legrand, PhD, PharmD, Amy D. Klion, MD The Journal of Allergy and Clinical Immunology: In Practice Volume 3, Issue 2, Pages 167-174 (March 2015) DOI: 10.1016/j.jaip.2015.01.013 Copyright © 2014 Terms and Conditions
Figure 1 Mechanism of action of biologic therapies for treatment of EAD. Agents targeting eosinophil surface receptors are shown in panel A and mediators associated with eosinophilic inflammation in vivo in panel B. MC = mast cell, baso = basophil. The Journal of Allergy and Clinical Immunology: In Practice 2015 3, 167-174DOI: (10.1016/j.jaip.2015.01.013) Copyright © 2014 Terms and Conditions